Generated by Meeveem AI
"Specialty vaccine company developing prophylactic vaccines for infectious diseases with unmet needs"
Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. The company has commercialized three vaccines, including a single shot chikungunya vaccine, and advanced vaccine candidates through clinical development for Lyme disease, Shigella and Zika. With over 700 employees across six countries, Valneva combines proven product development capabilities with an integrated business model. The company focuses on utilizing validated scientific approaches to advance late stage clinical programs toward regulatory approval and commercialization, aiming to become first, best or only in class.
700
Team Members
2013
Founded
Pharma
Sector
Hybrid
Work Environment
A world in which no one dies or suffers from a vaccine preventable disease.
Valneva develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.